Литература
1. Naghavi M., Abajobir A.A. et al. Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016 // Lancet. 2017. Vol. 390. P. 1151-1210.
2. Han H.R., Lee H., Commodore-Mensah Y., Kim M. Development and validation of the hypertension self-care profile: a practical tool to measure hypertension self-care // Eur.J. Cardiovasc. Nurs. 2014. Vol. 29. P. E11.
3. World Health Organization. Q&As on Hypertension, 2015. URL: www.who.int/features/qa/82/en/
4. Zipes D., Libby P. et al. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier, 2019.
5. Danaei G., Lu Y., Singh G.M. et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration // Lancet Diabetes Endocrinol. 2014. Vol. 2, N 8. P. 634-647. URL: https://pubmed.ncbi.nlm.nih.gov/24842598-cardiovascular-disease-chronic-kidney-disease-and-diabetes-mortality-burden-of-cardiometabolic-risk-factors-from-1980-to-2010-a-comparative-risk-assessment/. doi: 10.1016/S2213-8587(14)70102-0
6. Mannsverk J., Wilsgaard T. et al. Trends in modifable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population // Circulation. 2016. Vol. 133. P. 74-81.
7. Motlagh S.F.Z., Chaman R., Sadeghi E., Eslami A.A. Self-care behaviors and related factors in hypertensive patients // Iran. Red Crescent Med.J. 2016. Vol. 18. Article ID e35805. URL: https://pubmed.ncbi.nlm.nih.gov/27621938-self-care-behaviors-and-related-factors-in-hypertensive-patients/. doi: 10.5812/ircmj.35805
8. Баланова Ю.А., Шальнова С.А., Имаева А.Э., Капустина А.В. и др. Распространенность артериальной гипертонии, охват лечением и его эффективность в российской федерации (данные наблюдательного исследования ЭССЕ-РФ-2) // Рациональная фармакотер. в кардиологии. 2019. Т. 15, № 4. С. 450-466.
9. Золотовская И.А., Дупляков Д.В., Зюзина Т.В., Давыдкин И.Л. Клинико-фармакологические детерминанты пациентов с артериальной гипертензией старше 60 лет в условиях реальной клинической практики: результаты наблюдательной программы ГРАНАТ // Кардиология: новости, мнения, обучение. 2019. Т. 7, № 1 (20). С. 31-39.
10. Золотовская И.А., Дупляков Д.В., Зюзина Т.В., Давыдкин И.Л. Депрескрайбинг антигипертензивной терапии у пациентов с артериальной гипертензией старше 60 лет (результаты наблюдательной программы "ГРАНАТ") // Артериальная гипертензия. 2019. Т. 25, № 3. С. 267-277.
11. Abel W.M., Joyner J.S., Cornelius J.B., Greer D.B. Self-care management strategies used by black women who self-report consistent adherence to antihypertensive medication // Patient Prefer. Adherence. 2017. Vol. 11. P. 1401-1412.
12. Концевая А.В., Шальнова С.А., Баланова Ю.А., Деев А.Д. идр. Качество жизни российской популяции по данным исследования ЭССЕ-РФ // Кардиоваскуляр. тер. и профилактика. 2016. Т. 15, № 5. С. 84-91.
13. Оганов Р.Г., Денисов И.Н., Симаненков В.И., Бакулин ИГ. и др. Коморбидная патология в клинической практике. Клинические рекомендации // Кардиоваскуляр. тер. и профилактика. 2017. Т. 16, № 6. С. 5-56.
14. Конради А.О. Основные проблемы лечения артериальной гипертензии у пациентов с коморбидностью // Сердце: журнал для практикующих врачей. 2010. Т. 9, № 1 (51). С. 37-41.
15. Ashworth M., Durbaba S., Whitney D., Crompton J. et al. Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting // BMJ Open. 2019. Vol. 9, N 12. Article ID e031649. URL: https://pubmed.ncbi.nlm.nih.gov/31874873-journey-to-multimorbidity-longitudinal-analysis-exploring-cardiovascular-risk-factors-and-sociodemographic-determinants-in-an-urban-setting/. doi: 10.1136/bmjopen-2019-031649
16. Zhao Q.N., Wang C.X., Guan S.C., Liu H.J. et al. Prevalence characters of peripheral artery disease and associated factors among Beijing residents aged equal and above 35 years old // Zhonghua Xin Xue Guan Bing Za Zhi. 2019. Vol. 47, N 12. P. 10001004. URL: https://pubmed.ncbi.nlm.nih.gov/31877597-prevalence-characters-of-peripheral-artery-disease-and-associated-factors-among-beijing-residents-aged-equal-and-above-35-years-old/. doi: 10.3760/cma.j.issn.0253-3758.2019.12.010
17. Whelton P.K., Carey R.M., Aronow W.S., Casey D.E. et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines // J. Am. Coll. Cardiol. 2018. Vol. 71. P. e127-e248.
18. Malmivaara A., Meretoja A., Peltola M., Numerato D. et al. Comparing ischaemic stroke in six European countries. The EuroHOPE register study // Eur.J. Neurol. 2015. Vol. 22. P. 284-291.
19. Pistoia F., Sacco S., Degan D., Tiseo C. et al. Hypertension and stroke: epidemiological aspects and clinical evaluation // High Blood Press. Cardiovasc. Prev. 2016. Vol. 23, N 1. P. 9-18. URL: https://pubmed.ncbi.nlm.nih.gov/26159677-hypertension-and-stroke-epidemiological-aspects-and-clinical-evaluation/. doi: 10.1007/s40292-015-0115-2
20. Kernan W.N., Ovbiagele B., Black H.R., Bravata D.M. et al.; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association // Stroke. 2014. Vol. 45. P. 2160-2236.
21. Matsumoto A., Satoh M., Kikuya M., Ohkubo T. et al. Dayto-day variability in home blood pressure is associated with cognitive decline: the Ohasama study // Hypertension. 2014. Vol. 63. P. 13331338.
22. Kamon T., Kaneko H., Itoh H., Kiriyama H. et al. Gender-specific association between the blood pressure category according to the updated ACC/AHA guidelines for hypertension and cardio-ankle vascular index: a community-based cohort study // J. Cardiol. 2019 Dec 21. pii: S0914-5087 (19)30337-5. URL: https://www.journal-of-cardiology.com/article/S0914-5087(19)30337-5/fulltext. doi: 10.1016/j.jjcc.2019.10.007
23. Кочергина А.М., Каретникова В.Н., Барбараш О.Л. Гендерные различия факторов кардиоваскулярного риска у пациентов разных возрастных групп (по данным исследования ЭССЕ-РФ) // Медицина в Кузбассе. 2016. Т. 15, № 1. С. 75-82.
24. Townsend N., Nichols M., Scarborough P., Rayner M. Cardiovascular disease in Europe 2015: epidemiological update // Eur. Heart J. 2015. Vol. 36. P. 26 73 - 2 6 74.
25. Ramirez L.A., Sullivan J.C. Sex differences in hypertension: where we have been and where we are going // Am.J. Hypertens. 2018 Oct 9.
26. Tadic M., Cuspidi C., Grassi G., Ivanovic B. Gender-specific therapeutic approach in arterial hypertension - Challenges ahead // Pharmacol. Res. 2019. Vol. 141. P. 181-188. URL: https://pubmed.ncbi.nlm.nih.gov/30584913-gender-specific-therapeutic-approach-in-arterial-hypertension-challenges-ahead/. doi: 10.1016/j.phrs.2018.12.021
27. Parekh N., Page A., Ali K., Davies K. et al. A practical approach to the pharmacological management of hypertension in older people // Ther. Adv. Drug Saf. 2017. Vol. 8, N 4. P. 117-132. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394506/. doi: 10.1177/2042098616682721
28. Лузина А.В., Ткачёва ОН., Рунихина Н.К. Антигипертензивная терапия у пациентки с синдромом старческой астении. клинический случай // Доктор.Ру. 2019. № 2 (157). С. 23-26. URL: https://journaldoctor.ru/catalog/kardiologiya/antigipertenzivnaya-terapiya/. doi: 10.31550/1727-2378-2019-157-2-23-26
29. Sundstrom J., Lind L., Nowrouzi S., Lytsy P. et al. The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study // Ups.J. Med. Sci. 2019. Vol. 124, N 1. P. 51-58. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450492/. doi: 10.1080/03009734.2018.1498958
30. Davis B.R., Cutler J.A., Gordon D.J., Furberg C.D. et al. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Research Group // Am.J. Hypertens. 1996. Vol. 9. P. 342-360.
31. Johnson K., Oparil S., Davis B.R., Tereshchenko L.G. Prevention of heart failure in hypertension-disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study // J. Am. Heart Assoc. 2019. Vol. 8, N 8. Article ID e011961. URL: https://pubmed.ncbi.nlm.nih.gov/30943832. doi: 10.1161/JAHA.119.011961
32. Simonyi G., Ferenci T., Finta E., Igaz I. et al. One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients // Orv. Hetil. 2019. Vol. 160, N 9. P. 343-348. URL: https://pubmed.ncbi.nlm.nih.gov/30798621. doi: 10.1556/650.2019.31355
33. Dahlof B., Sever P.S., Poulter N.R. et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial // Lancet. 2005. Vol. 366. P. 895-906.
34. Павлова О.С., Ливенцева М.М., Коробко И.Ю., Калинина Т.В. и др. Преимущества использования комбинированного антигипертензивного препарата экватор в клинической практике // Кардиология в Беларуси. 2009. № 3 (4). С. 64-73.
35. Чазова И.Е., Ратова Л.Г., Недогода С.В., Лопатин Ю.М. и др. Применение фиксированной комбинации лизиноприла с амлодипи-ном у пациентов с артериальной гипертензией // Системные гипертензии. 2012. Т. 9, № 1. С. 14-17.
36. Асташкин Е.И., Глезер М.Г Механизмы комбинированного действия ингибиторов ангиотензин-превращающего фермента и антагонистов кальция при артериальной гипертонии. Кардиоваскулярная тер. и профилактика. 2013. Т. 12, № 3. С. 72-77.
37. Сушинский В.Э. Опыт клинического применения фиксированной комбинации ингибитора ангиотензинпревращающего фермента и антагониста кальция в лечении артериальной гипертензии // Мед. новости. 2016. № 2. С. 29-33.
38. Dymek J., Golda A., Polak W., Lisowski B. et al. Effect of education for hypertensive patients with correctly performed self-blood pressure monitoring (SBPM) // Pharmacy (Basel). 2019. Vol. 7. pii. E75.
39. Frieden T.R., Varghese C.V., Kishore S.P., Campbell N.R.C. et al. Scaling up effective treatment of hypertension - a pathfinder for universal health coverage // J. Clin. Hypertens 2019. Vol. 21. P. 14421449. URL: https://pubmed.ncbi.nlm.nih.gov/31544349-scaling-up-effective-treatment-of-hypertension-a-pathfinder-for-universal-health-coverage/. doi: 10.1111/jch.13655
References
1. Naghavi M., Abajobir A.A., et al. Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 1151-210.
2. Han H.R., Lee H., Commodore-Mensah Y., Kim M. Development and validation of the hypertension self-care profile: a practical tool to measure hypertension self-care. Eur J Cardiovasc Nurs. 2014; 29: E11.
3. World Health Organization. Q&As on Hypertension, 2015. URL: www.who.int/features/qa/82/en/
4. Zipes D., Libby P., et al. Braunwald’s heart disease: a textbook of cardiovascular medicine. 11th ed. Philadelphia: Elsevier, 2019.
5. Danaei G., Lu Y., Singh G.M., et al. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Lancet Diabetes Endocrinol. 2014; 2 (8): 634-47. URL: https://pubmed.ncbi.nlm.nih.gov/24842598-cardiovascular-disease-chronic-kidney-disease-and-diabetes-mortality-burden-of-cardiometabolic-risk-factors-from-1980-to-2010-a-comparative-risk-assessment/. doi: 10.1016/S2213-8587(14)70102-0
6. Mannsverk J., Wilsgaard T., et al. Trends in modifable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population. Circulation. 2016; 133: 74-81.
7. Motlagh S.F.Z., Chaman R., Sadeghi E., Eslami A.A. Selfcare behaviors and related factors in hypertensive patients. Iran Red Crescent Med.J. 2016; 18: e35805. URL: https://pubmed.ncbi.nlm.nih.gov/27621938-self-care-behaviors-and-related-factors-in-hypertensive-patients/. doi: 10.5812/ircmj.35805
8. Balanova Yu.A., Shal’nova S.A., Imaeva A.E., Kapustina A.V., et al.; on behalf of ESSE-RF-2 Researchers. Prevalence, awareness, treatment and control of hypertension in russian federation (data of observational ESSE-RF-2 study). Ratsional’naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology]. 2019; 15 (4): 450-66. (in Russian)
9. Zolotovskaya I.A., Duplyakov D.V., Zyuzina T.V., Davydkin I.L. Clinical and pharmacological determinants of patients with hypertension older than 60 years in real clinical practice: results of the observation program GRANAT. Kardiologiya: novosti, mneniya, obuchenie [Cardiology: News, Opinions, Training]. 2019; 7 (1): 31-9. doi: 10.24411/2309-1908-2019-11004. (in Russian)
10. Zolotovskaya I.A., Duplyakov D.V., Zyuzina T.V., Davydkin I.L. Deprescribing of hypotensive therapy in hypertensive patients over 60 years (results of the program "GRANAT"). Arterial’naya gipertenziya [Arterial Hypertension]. 2019; 25 (3): 267-77. URL: https:// doi.org/10.18705/1607-419X-2019-25-3-267-277. (in Russian)
11. Abel W.M., Joyner J.S., Cornelius J.B., Greer D.B. Self-care management strategies used by black women who self-report consistent adherence to antihypertensive medication. Patient Prefer Adherence. 2017; 11: 1401-12.
12. Kontsevaya A.V., Shal’nova S.A., Balanova Y.A., et al. Life quality of the Russian population by the data from ESSE-RF study. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2016; 15 (5): 84-90. URL: https://doi. org/10.15829/1728-8800-2016-5-84-90. (in Russian)
13. Oganov R.G., Denisov I.N., Simanenkov V.I., Bakulin I.G., et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2019; 18 (1): 5-66. URL: https://doi. org/10.15829/1728-8800-2019-1-5-66. (in Russian)
14. Conradi A.O. Main problems of treatment of arterial hypertension in patients with comorbidity Heart:journal for practitioners. Sertse [Heart]. 2010; 9 (1): 37-41. (in Russian)
15. Ashworth M., Durbaba S., Whitney D., Crompton J., et al. Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting. BMJ Open. 2019; 9 (12): e031649. URL: https://pubmed.ncbi.nlm.nih.gov/31874873-journey-to-multimorbidity-longitudinal-analysis-exploring-cardiovascular-risk-factors-and-sociodemographic-determinants-in-an-urban-setting/. doi: 10.1136/bmjopen-2019-031649
16. Zhao Q.N., Wang C.X., Guan S.C., Liu H.J., et al. Prevalence characters of peripheral artery disease and associated factors among Beijing residents aged equal and above 35 years old. Zhonghua Xin Xue Guan Bing Za Zhi. 2019; 47 (12): 1000-4. URL: https://pubmed.ncbi.nlm.nih.gov/31877597-prevalence-characters-of-peripheral-artery-disease-and-associated-factors-among-beijing-residents-aged-equal-and-above-35-years-old/. doi: 10.3760/cma.j.issn.0253-3758.2019.12.010
17. Whelton P.K., Carey R.M., Aronow W.S., Casey D.E., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 71: e127-248.
18. Malmivaara A., Meretoja A., Peltola M., Numerato D., et al. Comparing ischaemic stroke in six European countries. The EuroHOPE register study. Eur J Neurol. 2015; 22: 284-91.
19. Pistoia F., Sacco S., Degan D., Tiseo C., et al. Hypertension and stroke: epidemiological aspects and clinical evaluation. High Blood Press Cardiovasc Prev. 2016; 23 (1): 9-18. URL: https://pubmed.ncbi.nlm.nih.gov/26159677-hypertension-and-stroke-epidemiological-aspects-and-clinical-evaluation/. doi: 10.1007/s40292-015-0115-2
20. Kernan W.N., Ovbiagele B., Black H.R., Bravata D.M., et al.; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 2160-236.
21. Matsumoto A., Satoh M., Kikuya M., Ohkubo T., et al. Dayto-day variability in home blood pressure is associated with cognitive decline: the Ohasama study. Hypertension. 2014; 63: 1333-8.
22. Kamon T., Kaneko H., Itoh H., Kiriyama H., et al. Gender-specific association between the blood pressure category according to the updated ACC/AHA guidelines for hypertension and cardio-ankle vascular index: a community-based cohort study. J Cardiol 2019 Dec 21. pii: S0914-5087 (19)30337-5. URL: https://www.journal-of-cardiology.com/article/S0914-5087(19)30337-5/fulltext. doi: 10.1016/j.jjcc.2019.10.007
23. Kochergina A., Barbarash O., Karetnikova V. Gender specific differences of cardiovascular risk factors in different age groups. Meditsina v Kuzbasse [Medicine in Kuzbass]. 2016; 15 (1): 75-82. (in Russian)
24. Townsend N., Nichols M., Scarborough P., Rayner M. Cardiovascular disease in Europe 2015: epidemiological update. Eur Heart J. 2015; 36: 2673-4.
25. Ramirez L.A., Sullivan J.C. Sex differences in hypertension: where we have been and where we are going. Am J Hypertens. 2018 Oct 9.
26. Tadic M., Cuspidi C., Grassi G., Ivanovic B. Gender-specific therapeutic approach in arterial hypertension - Challenges ahead. Pharmacol Res. 2019; 141: 181-8. URL: https://pubmed.ncbi.nlm.nih.gov/30584913-gender-specific-therapeutic-approach-in-arterial-hypertension-challenges-ahead/. doi: 10.1016/j.phrs.2018.12.021
27. Parekh N., Page A., Ali K., Davies K., et al. A practical approach to the pharmacological management of hypertension in older people. Ther Adv Drug Saf. 2017; 8 (4): 117-32. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394506/. doi: 10.1177/2042098616682721
28. Luzina A.V., Tkacheva O.N., Runikhina N.K. Antihypertensive treatment for a female patient with frailty syndrome: a case report. Doctor.Ru. 2019; 2 (157): 23-6. (in Russian) URL: https://journaldoctor.ru/catalog/kardiologiya/antigipertenzivnaya-terapiya/. doi: 10.31550/1727-2378-2019-157-2-23-26
29. Sundstrom J., Lind L., Nowrouzi S., Lytsy P., et al. The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study. Ups J Med Sci. 2019; 124 (1): 51-8 URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450492/. doi: 10.1080/03009734.2018.1498958
30. Davis B.R., Cutler J.A., Gordon D.J., Furberg C.D., et al. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Research Group. Am J Hypertens. 1996; 9: 342-60.
31. Johnson K., Oparil S., Davis B.R., Tereshchenko L.G. Prevention of heart failure in hypertension-disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study. J Am Heart Assoc. 2019; 8 (8): e011961. URL: https://pubmed.ncbi.nlm.nih.gov/30943832. doi: 10.1161/JAHA.119.011961
32. Simonyi G., Ferenci T., Finta E., Igaz I., et al. One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients. Orv Hetil. 2019; 160 (9): 343-8. URL: https://pubmed.ncbi.nlm.nih.gov/30798621. doi: 10.1556/650.2019.31355
33. Dahlof B., Sever P.S., Poulter N.R., et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005; 366: 895-906.
34. Pavlova O.S., Liventseva M.M., Korobko I.Yu., Kalinina T.V., et al. Advantages of using the combined antihypertensive drug equator in clinical practice. Kardiologia v Belarusii [Cardiology in Belarus]. 2009; 3 (4): 64-73. (in Russian)
35. Chazova I.E., Ratova L.G., Nedogoda S.V., Lopatin Yu.M., et al. Application of a fixed combination of lisinopril with amlodipine in patients with arterial hypertension. Sistemnye gipertenzii [Systemic Hypertension]. 2012; 9 (1): 14-7. (in Russian)
36. Astashkin E.I., Glezer M.G. Mechanisms of combined action of ace inhibitors and calcium antagonists in arterial hypertension. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2013; 12 (3): 72-7. URL: https://doi.org/10.15829/1728-8800-2013-3-72-77. (in Russian)
37. Sushynski V.E. Belarusian Medical Academy of Post-Graduate Education, Minsk, Belarus Experience of clinical administration of inhibitor fixed combination of angiotensine transforming enzyme and calcium antagonist in the treatment of arterial hypertension. Meditsinskie novosti [Medical News]. 2016; (2): 29-33. (in Russian)
38. Dymek J., Golda A., Polak W., Lisowski B., et al. Effect of education for hypertensive patients with correctly performed self-blood pressure monitoring (SBPM). Pharmacy (Basel). 2019; 7: pii. E75.
39. Frieden T.R., Varghese C.V., Kishore S.P., Campbell N.R.C., et al. Scaling up effective treatment of hypertension - a pathfinder for universal health coverage. J Clin Hypertens 2019; 21: 1442-9. URL: https://pubmed.ncbi.nlm.nih.gov/31544349-scaling-up-effective-treatment-of-hypertension-a-pathfinder-for-universal-health-coverage/. doi: 10.1111/jch.13655